- Home
- FENC vs NVX Comparison
FENC vs NVX Comparison
Compare FENC & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- NVX
- Stock Information
- Founded
- FENC 1996
- NVX 2012
- Country
- FENC United States
- NVX Australia
- Employees
- FENC N/A
- NVX N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- NVX Industrial Machinery/Components
- Sector
- FENC Health Care
- NVX Miscellaneous
- Exchange
- FENC Nasdaq
- NVX Nasdaq
- Market Cap
- FENC 156.9M
- NVX 174.9M
- IPO Year
- FENC 2001
- NVX N/A
- Fundamental
- Price
- FENC $6.09
- NVX $1.14
- Analyst Decision
- FENC Strong Buy
- NVX Strong Buy
- Analyst Count
- FENC 2
- NVX 1
- Target Price
- FENC $14.00
- NVX $4.00
- AVG Volume (30 Days)
- FENC 120.6K
- NVX 82.0K
- Earning Date
- FENC 03-10-2025
- NVX 01-01-0001
- Dividend Yield
- FENC N/A
- NVX N/A
- EPS Growth
- FENC N/A
- NVX N/A
- EPS
- FENC N/A
- NVX N/A
- Revenue
- FENC $47,538,000.00
- NVX $5,854,424.00
- Revenue This Year
- FENC $28.99
- NVX $66.66
- Revenue Next Year
- FENC $63.21
- NVX $2,366.64
- P/E Ratio
- FENC N/A
- NVX N/A
- Revenue Growth
- FENC 123.69
- NVX N/A
- 52 Week Low
- FENC $3.96
- NVX $0.97
- 52 Week High
- FENC $11.29
- NVX $3.10
- Technical
- Relative Strength Index (RSI)
- FENC 39.43
- NVX 43.00
- Support Level
- FENC $6.25
- NVX $1.24
- Resistance Level
- FENC $6.90
- NVX $1.31
- Average True Range (ATR)
- FENC 0.34
- NVX 0.07
- MACD
- FENC -0.04
- NVX 0.02
- Stochastic Oscillator
- FENC 19.82
- NVX 22.78
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.